Baxter has three manufacturing facilities in Puerto Rico, all of which are operating on limited manufacturing capacity. As a result, many U.S. hospitals are experiencing shortages of Baxter’s IV products.
Baxter CEO José Almeida told analysts the company should achieve normal inventory levels for affected products — and see little financial impact from the supply chain disruptions — by the first quarter of 2018, according to Reuters.
More articles on supply chain:
FDA OKs expanded use for Alexion’s ultra-rare disease drug
Survey: 61% of patient advocacy groups have favorable view of devicemakers
Hospitals grapple with medical supply shortages in wake of Hurricane Maria: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
